The Roles of Insulin-Like Growth Factors in Mesenchymal Stem Cell Niche
April 1, 2026: Lawsuits Involving Ozempic & Other GLP-1s Climb to Over 3,500 Ozempics manufacturer, Novo Nordisk, and one other GLP-1 company are facing about 3,546 lawsuits in an active, federally consolidated MDL filed by former patients and their loved ones
I started in December 2023, shortly after it went on the market
Higher eumelanin levels are generally associated with better absorption and dissipation of UV radiation, helping reduce DNA damage and preserve skin integrity over time
Novo Nordisk has several GLP-1-based products for treating Type 2 diabetes: Ozempic (semaglutide, injection), Rybelsus (semaglutide, tablets), and Victoza (liraglutide)
Use of multivariable Mendelian randomization to address biases due to competing risk before recruitment